SALIX PHARMACEUTICALS LTD Net Change in Cash
SALIX PHARMACEUTICALS LTD reported Net Change in Cash of -$658.51 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD cash and cash equivalents, period increase (decrease) for the quarter ending 2014-12-31 was $76.76M, a 77.43% decline year-over-year.
- SALIX PHARMACEUTICALS LTD cash and cash equivalents, period increase (decrease) for the quarter ending 2014-09-30 was -$12.68M.
- SALIX PHARMACEUTICALS LTD cash and cash equivalents, period increase (decrease) for the quarter ending 2014-06-30 was $50.16M.
- SALIX PHARMACEUTICALS LTD cash and cash equivalents, period increase (decrease) for the quarter ending 2014-03-31 was -$772.75M, a 469.24% decline year-over-year.
- SALIX PHARMACEUTICALS LTD cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$658.51M, a 261.86% decline from fiscal 2013.
- SALIX PHARMACEUTICALS LTD cash and cash equivalents, period increase (decrease) for fiscal 2013 was $406.84M, a 11.21% decline from fiscal 2012.
- SALIX PHARMACEUTICALS LTD cash and cash equivalents, period increase (decrease) for fiscal 2012 was $458.19M.
- SALIX PHARMACEUTICALS LTD cash and cash equivalents, period increase (decrease) for fiscal 2011 was -$225.22M, a 169.19% decline from fiscal 2010.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2014-12-31 | $76.76M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $64.08M derived: sum of 2 quarters · filed 2015-03-02 | $114.24M derived: sum of 3 quarters · filed 2015-03-02 | -$658.51M 10-K · filed 2015-03-02 |
| 2014-09-30 | -$12.68M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02 | $37.48M derived: sum of 2 quarters · filed 2015-03-02 | -$735.27M 10-Q/A · filed 2015-03-02 | -$395.15M derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-06-30 | $50.16M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02 | -$722.59M 10-Q/A · filed 2015-03-02 | -$382.46M derived: sum of 3 quarters · filed 2015-03-02 | -$382.72M derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-03-31 | -$772.75M 10-Q/A · filed 2015-03-02 | -$432.62M derived: sum of 2 quarters · filed 2015-03-02 | -$432.88M derived: sum of 3 quarters · filed 2015-03-02 | -$575.18M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-12-31 | $340.13M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $339.87M derived: sum of 2 quarters · filed 2015-03-02 | $197.56M derived: sum of 3 quarters · filed 2015-03-02 | $406.84M 10-K · filed 2015-03-02 |
| 2013-09-30 | -$257.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02 | -$142.56M derived: sum of 2 quarters · filed 2015-03-02 | $66.72M 10-Q/A · filed 2015-03-02 | $41.82M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$142.30M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02 | $66.98M 10-Q/A · filed 2015-03-02 | $42.08M derived: sum of 3 quarters · filed 2015-03-02 | $102.06M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $209.28M 10-Q/A · filed 2015-03-02 | $184.38M derived: sum of 2 quarters · filed 2015-03-02 | $244.36M derived: sum of 3 quarters · filed 2015-03-02 | $294.42M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$24.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $35.08M derived: sum of 2 quarters · filed 2015-03-02 | $85.14M derived: sum of 3 quarters · filed 2015-03-02 | $458.19M 10-K · filed 2015-03-02 |
| 2012-09-30 | $59.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $110.04M derived: sum of 2 quarters · filed 2013-11-08 | $483.09M 10-Q · filed 2013-11-08 | $277.67M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-06-30 | $50.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $423.11M 10-Q · filed 2013-08-09 | $217.70M derived: sum of 3 quarters · filed 2015-03-02 | $239.41M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-03-31 | $373.05M 10-Q · filed 2013-05-10 | $167.64M derived: sum of 2 quarters · filed 2015-03-02 | $189.35M derived: sum of 3 quarters · filed 2015-03-02 | $156.61M derived: sum of 4 quarters · filed 2015-03-02 |
| 2011-12-31 | -$205.41M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$183.71M derived: sum of 2 quarters · filed 2015-03-02 | -$216.44M derived: sum of 3 quarters · filed 2015-03-02 | -$225.22M 10-K · filed 2015-03-02 |
| 2011-09-30 | $21.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$11.03M derived: sum of 2 quarters · filed 2012-11-08 | -$19.80M 10-Q · filed 2012-11-08 | $6.76M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | -$32.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$41.51M 10-Q · filed 2012-08-09 | -$14.95M derived: sum of 3 quarters · filed 2013-03-01 | $15.27M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | -$8.78M 10-Q · filed 2012-05-08 | $17.79M derived: sum of 2 quarters · filed 2013-03-01 | $48.01M derived: sum of 3 quarters · filed 2013-03-01 | $311.21M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $26.56M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $56.78M derived: sum of 2 quarters · filed 2013-03-01 | $319.99M derived: sum of 3 quarters · filed 2013-03-01 | $325.52M 10-K · filed 2013-03-01 |
| 2010-09-30 | $30.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $293.42M derived: sum of 2 quarters · filed 2011-11-09 | $298.95M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $263.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $268.73M 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | $5.53M 10-Q · filed 2011-05-10 | |||
| 2009-12-31 | $72.36M 10-K · filed 2012-02-28 |